Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial.

Fatemeh VazirianSara SamadiMohammadreza AbbaspourAmirmahdi TalebHadi BagherhosseiniHooman Mosannen MozaffariAmir Hooshang MohammadpourSeyed Ahmad Emami

Published in: Inflammopharmacology (2022)

Administration of Thymus kotschyanus revealed improvement in UC symptoms by the intestinal anti-inflammation effect of the plant and could be suggested as a potential additive treatment in UC patients. The study protocol has been registered under the identification code: IRCT20200406046965N2.

Keyphrases

study protocol
double blind
end stage renal disease
oxidative stress
clinical trial
ejection fraction
newly diagnosed
chronic kidney disease
placebo controlled
peritoneal dialysis
combination therapy
physical activity
single cell
risk assessment
open label
patient reported outcomes
bioinformatics analysis